Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Optiscan Imaging Limited ( (AU:OIL) ) has issued an announcement.
Optiscan Imaging Limited has announced a pro-rata renounceable rights issue to raise approximately $17.75 million, offering one new share for every four shares held at $0.085 per share. The funds will be used for clinical studies, regulatory approvals, and commercialization of its medical devices, with the offer fully underwritten by Peters Investments Pty Ltd. Ineligible shareholders from outside Australia, New Zealand, and Singapore will have their entitlements sold by a nominee, with proceeds distributed after expenses.
More about Optiscan Imaging Limited
Optiscan Imaging Limited operates in the medical imaging industry, focusing on the development and commercialization of clinical medical devices such as InVue®, InForm™, and InSpecta™. The company is dedicated to advancing its flexible endomicroscope technology and aims to secure US regulatory approvals for its products.
Average Trading Volume: 129,294
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$99.2M
See more data about OIL stock on TipRanks’ Stock Analysis page.